Recent biomedical advancements in graphene oxide- and reduced graphene oxide-based nanocomposite nanocarriers

Recently, nanocarriers, including micelles, polymers, carbon-based materials, liposomes, and other substances, have been developed for efficient delivery of drugs, nucleotides, and biomolecules. This review focuses on graphene oxide (GO) and reduced graphene oxide (rGO) as active components in nanocarriers, because their chemical structures and easy functionalization can be valuable assets for in vitro and in vivo delivery. Herein, we describe the preparation, structure, and functionalization of GO and rGO. Additionally, their important properties to function as nanocarriers are presented, including their molecular interactions with various compounds, near-infrared light adsorption, and biocompatibility. Subsequently, their mechanisms and the most appealing examples of their delivery applications are summarized. Overall, GO- and rGO-based nanocomposites show great promise as multipurpose nanocarriers owing to their various potential applications in drug and gene delivery, phototherapy, bioimaging, biosensing, tissue engineering, and as antibacterial agents.

Automated summary

This review focuses on graphene oxide (GO) and reduced graphene oxide (rGO) as active components in nanocarriers, and describes their preparation, structure, functionalization, and important properties for drug delivery. The mechanisms and appealing examples of their delivery applications are also summarized. GO- and rGO-based nanocomposites show great promise as multipurpose nanocarriers for various applications.